REVIEU - A multinational, retrospective, observational drug utilisation study of REVOLADE⢠(eltrombopag) In selected countries in the European Union (201108) First published 30/06/2014 Last updated 02/07/2024 EU PAS number:EUPAS6969 Study Finalised